CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,173 | -89.7% | 1,940 | -90.4% | 0.00% | – |
| Q1 2023 | $21,116 | +721.0% | 20,304 | +784.3% | 0.00% | – |
| Q4 2022 | $2,572 | +157.2% | 2,296 | +108.7% | 0.00% | – |
| Q3 2022 | $1,000 | – | 1,100 | +766.1% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 127 | -0.8% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 128 | -84.5% | 0.00% | – |
| Q4 2018 | $1,000 | -99.9% | 828 | -99.5% | 0.00% | – |
| Q3 2018 | $1,086,000 | -61.1% | 176,629 | -32.3% | 0.00% | – |
| Q2 2018 | $2,789,000 | -27.8% | 260,909 | -27.5% | 0.00% | – |
| Q1 2018 | $3,864,000 | +3.3% | 360,086 | -32.6% | 0.00% | – |
| Q4 2017 | $3,741,000 | -56.4% | 534,447 | -45.5% | 0.00% | -100.0% |
| Q3 2017 | $8,576,000 | -4.1% | 981,200 | -0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,940,000 | +26.6% | 981,292 | +10.4% | 0.00% | 0.0% |
| Q1 2017 | $7,059,000 | -23.3% | 889,100 | -13.6% | 0.00% | 0.0% |
| Q4 2016 | $9,205,000 | +145.9% | 1,029,600 | +377.3% | 0.00% | – |
| Q3 2016 | $3,743,000 | – | 215,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,462,500 | $11,993,000 | 6.16% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $6,410,000 | 2.56% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,430,000 | 0.82% |
| RTW INVESTMENTS, LP | 4,206,765 | $20,487,000 | 0.31% |
| Carmignac Gestion | 3,419,877 | $16,655,000 | 0.19% |
| EAM Investors, LLC | 247,561 | $1,206,000 | 0.19% |
| Curi Wealth Management, LLC | 25,000 | $121,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,542,000 | 0.03% |
| TWO SIGMA ADVISERS, LP | 990,000 | $4,821,000 | 0.01% |
| CAXTON ASSOCIATES LP | 24,677 | $120,000 | 0.01% |